We are live on ! Find out more
BSX icon

Boston Scientific

455 hedge funds and large institutions have $16.5B invested in Boston Scientific in 2014 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 151 increasing their positions, 163 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 42

11% more capital invested

Capital invested by funds: $14.8B → $16.5B (+$1.64B)

5% more funds holding

Funds holding: 435455 (+20)

0.31% more ownership

Funds ownership: 90.16%90.48% (+0.31%)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

7% less repeat investments, than reductions

Existing positions increased: 151 | Existing positions reduced: 163

52% less call options, than puts

Call options by funds: $49.1M | Put options by funds: $101M

Holders
455
Holders Change
+20
Holders Change %
+4.6%
% of All Funds
12.14%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
69
Increased
151
Reduced
163
Closed
42
Calls
$49.1M
Puts
$101M
Net Calls
-$52.3M
Net Calls Change
-$90.9M
Name Holding Trade Value Shares
Change
Change in
Stake
B
226
Barings
North Carolina
$1.83M -$116K -9,100 -6%
GL
227
GLG LLC
New York
$1.82M -$3.13M -244,459 -64%
PRC
228
Platte River Capital
Colorado
$1.77M -$565K -44,200 -25%
CIBC Asset Management
229
CIBC Asset Management
Ontario, Canada
$1.71M -$435K -34,027 -21%
SAM
230
Securian Asset Management
Minnesota
$1.59M +$39K +3,049 +3%
CBOA
231
Commonwealth Bank of Australia
Australia
$1.58M -$340K -26,628 -18%
AP
232
AHL Partners
United Kingdom
$1.55M +$498K +38,938 +50%
SMDAM
233
Sumitomo Mitsui DS Asset Management
Japan
$1.49M -$154K -12,011 -10%
DnB Asset Management
234
DnB Asset Management
Norway
$1.46M +$212K +16,600 +18%
SIG
235
Schooner Investment Group
Pennsylvania
$1.45M -$2.75M -215,000 -66%
LS
236
Livforsakringsbolaget Skandia
Sweden
$1.43M -$1.09M -84,900 -44%
GMIM
237
General Motors Investment Management
New York
$1.39M +$1.34M +104,656 New
HCC
238
Hirtle Callaghan & Co
Pennsylvania
$1.38M +$1.33M +104,047 New
LSERS
239
Louisiana State Employees Retirement System
Louisiana
$1.32M -$25.6K -2,000 -2%
KRS
240
Kentucky Retirement Systems
Kentucky
$1.31M -$57.9K -4,530 -4%
PA
241
Profund Advisors
Maryland
$1.3M +$197K +15,390 +19%
FC
242
Fairpointe Capital
Illinois
$1.29M +$382K +29,850 +44%
NLI
243
Nippon Life Insurance
Japan
$1.29M +$534K +41,773 +76%
AMI
244
Amica Mutual Insurance
Rhode Island
$1.28M
SB
245
Suntrust Banks
Georgia
$1.24M -$59.1K -4,623 -5%
GC
246
Globeflex Capital
California
$1.23M -$3.76M -294,328 -76%
Mirae Asset Global Investments
247
Mirae Asset Global Investments
South Korea
$1.23M +$1.18M +92,593 New
Marshall Wace
248
Marshall Wace
United Kingdom
$1.2M -$3.14M -245,322 -73%
PI
249
Placemark Investments
Illinois
$1.2M -$354K -27,670 -23%
CIM
250
CenturyLink Investment Management
Colorado
$1.2M

BSX Hedge Fund Activity: Q4 2014 in Review

455 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2014, worth a combined $16.5B — up 11% from $14.8B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new BSX positions and 42 closed out — a net gain of 27 holders — while 151 added to existing stakes and 163 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $207M. The largest seller was Dodge & Cox, cutting an estimated $553M.

  • 455 institutional investors held Boston Scientific (BSX) as of Q4 2014, up from 435 in Q3 2014.
  • Funds reported $16.5B of Boston Scientific stock for Q4 2014, up 11% quarter-over-quarter.
  • 69 funds opened new Boston Scientific positions in Q4 2014 and 42 closed out, a net change of +27 holders.
  • The largest Boston Scientific buyer in Q4 2014 was Fidelity Investments, an estimated $207M added.
  • The largest Boston Scientific seller in Q4 2014 was Dodge & Cox, an estimated $553M sold.

Based on aggregated 13F filings for Q4 2014.